Jacobson Pharma Corp Ltd is an investment holding company. It is principally engaged in the development, production, marketing and sale of pharmaceutical products. The company's operating segment include Generic drugs; Proprietary medicines and Wholesale and retail. Generic drugs segment develops, manufactures and distributes a host of off-patent medicines for various therapeutic use. It generates maximum revenue from the Generic drugs segment. Geographically, it derives a majority of revenue from Hong Kong and also has a presence in Mainland China, Macau, Singapore, and Other Countries.